These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24133169)

  • 1. IFN-γ-induced priming maintains long-term strain-transcending immunity against blood-stage Plasmodium chabaudi malaria.
    da Silva HB; de Salles EM; Panatieri RH; Boscardin SB; Rodríguez-Málaga SM; Alvarez JM; D'Império Lima MR
    J Immunol; 2013 Nov; 191(10):5160-9. PubMed ID: 24133169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites.
    Taylor PR; Seixas E; Walport MJ; Langhorne J; Botto M
    Infect Immun; 2001 Jun; 69(6):3853-9. PubMed ID: 11349051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites.
    Rummel T; Batchelder J; Flaherty P; LaFleur G; Nanavati P; Burns JM; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5768-74. PubMed ID: 15385476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria.
    van der Heyde HC; Elloso MM; Chang WL; Kaplan M; Manning DD; Weidanz WP
    J Immunol; 1995 Apr; 154(8):3985-90. PubMed ID: 7706737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient attenuated Foxp3 expression on CD4⁺ T cells treated with 7D4 mAb contributes to the control of parasite burden in DBA / 2 mice infected with lethal Plasmodium chabaudi chabaudi AS.
    Feng H; Zhu XT; Qi ZM; Wang QH; Wang GG; Pan YY; Li Y; Zheng L; Jiang YJ; Shang H; Cui L; Cao YM
    Scand J Immunol; 2012 Jan; 75(1):46-53. PubMed ID: 21916916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection.
    Haque A; Best SE; Ammerdorffer A; Desbarrieres L; de Oca MM; Amante FH; de Labastida Rivera F; Hertzog P; Boyle GM; Hill GR; Engwerda CR
    Eur J Immunol; 2011 Sep; 41(9):2688-98. PubMed ID: 21674481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism.
    Stevenson MM; Tam MF; Wolf SF; Sher A
    J Immunol; 1995 Sep; 155(5):2545-56. PubMed ID: 7650384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the spleen B-cell compartment at the early and late blood-stage Plasmodium chabaudi malaria.
    Castillo-Méndez SI; Zago CA; Sardinha LR; Freitas do Rosário AP; Alvarez JM; D'Império Lima MR
    Scand J Immunol; 2007; 66(2-3):309-19. PubMed ID: 17635808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MyD88-dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria.
    Franklin BS; Rodrigues SO; Antonelli LR; Oliveira RV; Goncalves AM; Sales-Junior PA; Valente EP; Alvarez-Leite JI; Ropert C; Golenbock DT; Gazzinelli RT
    Microbes Infect; 2007 Jun; 9(7):881-90. PubMed ID: 17537666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium chabaudi adami: interferon-gamma but not IL-2 is essential for the expression of cell-mediated immunity against blood-stage parasites in mice.
    Batchelder JM; Burns JM; Cigel FK; Lieberg H; Manning DD; Pepper BJ; Yañez DM; van der Heyde H; Weidanz WP
    Exp Parasitol; 2003 Oct; 105(2):159-66. PubMed ID: 14969693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.
    Malu DT; Bélanger B; Desautels F; Kelendji K; Dalko E; Sanchez-Dardon J; Leng L; Bucala R; Satoskar AR; Scorza T
    J Immunol; 2011 Jun; 186(11):6271-9. PubMed ID: 21518974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection.
    Linke A; Kühn R; Müller W; Honarvar N; Li C; Langhorne J
    Exp Parasitol; 1996 Nov; 84(2):253-63. PubMed ID: 8932775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect.
    Pouniotis DS; Proudfoot O; Bogdanoska V; Apostolopoulos V; Fifis T; Plebanski M
    Infect Immun; 2004 Sep; 72(9):5331-9. PubMed ID: 15322030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spleen CD4+ T cell response to blood-stage Plasmodium chabaudi malaria develops in two phases characterized by different properties.
    Muxel SM; Freitas do Rosário AP; Zago CA; Castillo-Méndez SI; Sardinha LR; Rodriguez-Málaga SM; Câmara NO; Álvarez JM; Lima MR
    PLoS One; 2011; 6(7):e22434. PubMed ID: 21814579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
    Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
    Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired macrophage responses may contribute to exacerbation of blood-stage Plasmodium chabaudi chabaudi malaria in interleukin-12-deficient mice.
    Bastos KR; Barboza R; Elias RM; Sardinha LR; Grisotto MG; Marinho CR; Amarante-Mendes GP; Alvarez JM; Lima MR
    J Interferon Cytokine Res; 2002 Dec; 22(12):1191-9. PubMed ID: 12581492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gradual decline in malaria-specific memory T cell responses leads to failure to maintain long-term protective immunity to Plasmodium chabaudi AS despite persistence of B cell memory and circulating antibody.
    Freitas do Rosário AP; Muxel SM; Rodríguez-Málaga SM; Sardinha LR; Zago CA; Castillo-Méndez SI; Alvarez JM; D'Império Lima MR
    J Immunol; 2008 Dec; 181(12):8344-55. PubMed ID: 19050251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasitaemia levels in Plasmodium chabaudi infected-mice modify IFN-gamma and IL-10 expression after a homologous or heterologous challenge.
    Aguilar-Medina M; Ramos-Payán R; Arámbula-Meraz E; Sánchez-Torres L; Favila-Castillo L
    Parasite Immunol; 2010 Apr; 32(4):267-74. PubMed ID: 20398227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-2 treatment impairs the expansion of T(reg) cell population during acute malaria and enhances the Th1 cell response at the chronic disease.
    Zago CA; Bortoluci KR; Sardinha LR; Pretel FD; Castillo-Méndez SI; Freitas do Rosário AP; Hiyane MI; Muxel SM; Rodriguez-Málaga SM; Abrahamsohn IA; Álvarez JM; D'Império Lima MR
    PLoS One; 2012; 7(1):e29894. PubMed ID: 22272258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.